Age-related trends in aperiodic EEG activity and alpha oscillations during early- to middle-childhood.

Aperiodic activity EEG FOOOF Functional brain development Periodic alpha oscillations Specparam

Journal

NeuroImage
ISSN: 1095-9572
Titre abrégé: Neuroimage
Pays: United States
ID NLM: 9215515

Informations de publication

Date de publication:
01 04 2023
Historique:
received: 12 06 2022
revised: 30 01 2023
accepted: 01 02 2023
pubmed: 5 2 2023
medline: 4 3 2023
entrez: 4 2 2023
Statut: ppublish

Résumé

Age-related structural and functional changes that occur during brain development are critical for cortical development and functioning. Previous electroencephalography (EEG) and magnetoencephalography (MEG) studies have highlighted the utility of power spectra analyses and have uncovered age-related trends that reflect perceptual, cognitive, and behavioural states as well as their underlying neurophysiology. The aim of the current study was to investigate age-related change in aperiodic and periodic alpha activity across a large sample of pre- and school-aged children (N = 502, age range 4 -11-years-of-age). Power spectra were extracted from baseline EEG recordings (eyes closed, eyes open) for each participant and parameterized into aperiodic activity to derive the offset and exponent parameters and periodic alpha oscillatory activity to derive the alpha peak frequency and the associated power estimates. Multilevel models were run to investigate age-related trends and condition-dependent changes for each of these measures. We found quadratic age-related effects for both the aperiodic offset and exponent. In addition, we observed increases in periodic alpha peak frequency as a function of age. Aperiodic measures and periodic alpha power were larger in magnitude during eyes closed compared to the eyes open baseline condition. Taken together, these results advance our understanding of the maturational patterns/trajectories of brain development during early- to middle-childhood.

Identifiants

pubmed: 36739102
pii: S1053-8119(23)00073-3
doi: 10.1016/j.neuroimage.2023.119925
pmc: PMC10701700
mid: NIHMS1941707
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

119925

Subventions

Organisme : NIH HHS
ID : UG3 OD023279
Pays : United States
Organisme : NIH HHS
ID : UH3 OD023279
Pays : United States

Informations de copyright

Copyright © 2023. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare no conflicts of interest

Références

Psychophysiology. 2022 May;59(5):e13901
pubmed: 34287923
Dev Cogn Neurosci. 2021 Aug;50:100969
pubmed: 34174512
J Neurosci. 2009 Oct 28;29(43):13613-20
pubmed: 19864573
Clin Neurophysiol. 2008 Aug;119(8):1778-1781
pubmed: 18486545
Int J Dev Neurosci. 2014 Nov;38:127-37
pubmed: 25219895
J Neurosci Methods. 2004 Mar 15;134(1):9-21
pubmed: 15102499
Brain Topogr. 2017 Jan;30(1):87-97
pubmed: 27766459
Hum Brain Mapp. 2014 Oct;35(10):5249-61
pubmed: 24861830
Neuroinformatics. 2022 Oct;20(4):991-1012
pubmed: 35389160
J Neurosci Methods. 2010 Sep 30;192(1):152-62
pubmed: 20654646
Psychophysiology. 2023 Jan;60(1):e14158
pubmed: 35968705
J Cogn Neurosci. 2017 Jul;29(7):1302-1310
pubmed: 28294717
J Neurosci. 2015 Sep 23;35(38):13257-65
pubmed: 26400953
Hum Brain Mapp. 2007 Mar;28(3):228-37
pubmed: 16767769
Neuron. 2010 May 13;66(3):353-69
pubmed: 20471349
Brain Sci. 2021 Jan 13;11(1):
pubmed: 33450814
Paediatr Perinat Epidemiol. 2014 Sep;28(5):455-65
pubmed: 25131605
Dev Psychobiol. 2022 May;64(4):e22271
pubmed: 35452546
Dev Cogn Neurosci. 2021 Apr;48:100938
pubmed: 33714056
Dev Cogn Neurosci. 2021 Feb;47:100895
pubmed: 33316695
Pediatr Res. 2022 Nov;92(5):1215-1216
pubmed: 34131291
J Neurodev Disord. 2019 Jul 31;11(1):15
pubmed: 31362710
Neuroimage. 2015 Sep;118:237-47
pubmed: 26057595
Eur J Neurosci. 2018 Mar;47(6):643-651
pubmed: 28700096
Trends Cogn Sci. 2012 Dec;16(12):606-17
pubmed: 23141428
Dev Cogn Neurosci. 2022 Apr;54:101073
pubmed: 35074579
Nat Neurosci. 2020 Dec;23(12):1655-1665
pubmed: 33230329
Neuroscience. 2011 Feb 3;174:10-25
pubmed: 21115101
Clin Neurophysiol. 2004 Mar;115(3):665-73
pubmed: 15036063
Dev Cogn Neurosci. 2021 Dec;52:101035
pubmed: 34781249
J Neurophysiol. 2019 Dec 1;122(6):2427-2437
pubmed: 31619109
Proc Natl Acad Sci U S A. 2004 May 25;101(21):8174-9
pubmed: 15148381
Brain Cogn. 2010 Feb;72(1):86-100
pubmed: 19914761
Trends Cogn Sci. 2014 Sep;18(9):480-7
pubmed: 24788139
Dev Cogn Neurosci. 2021 Apr;48:100931
pubmed: 33535138
Front Hum Neurosci. 2010 Nov 04;4:186
pubmed: 21119777
Electroencephalogr Clin Neurophysiol. 1989 Feb;72(2):184-7
pubmed: 2464490
Neuroimage. 2014 Jan 15;85 Pt 2:711-20
pubmed: 24018305
Neuroimage. 2022 Feb 15;247:118746
pubmed: 34875382
J Neurophysiol. 2015 Jul;114(1):505-19
pubmed: 25855698
Dev Cogn Neurosci. 2022 Apr;54:101076
pubmed: 35085871
Dev Sci. 2018 Nov;21(6):e12691
pubmed: 29863816
Neuroimage. 2019 Sep;198:13-30
pubmed: 31100431
Clin Neurophysiol. 2001 May;112(5):806-14
pubmed: 11336896
Psychophysiology. 2011 Feb;48(2):229-40
pubmed: 20636297
Brain Res. 2018 Jul 15;1691:34-43
pubmed: 29679544
Psychophysiology. 2020 Jun;57(6):e13580
pubmed: 32293719
Neuroimage. 2017 Sep;158:70-78
pubmed: 28676297
Psychophysiology. 2020 Aug;57(8):e13566
pubmed: 32185818
BMC Neurosci. 2012 Aug 24;13:104
pubmed: 22920159
Mol Autism. 2021 Feb 25;12(1):17
pubmed: 33632320
Dev Sci. 2011 Sep;14(5):935-43
pubmed: 21884309
Clin Neurophysiol. 1999 Aug;110(8):1399-409
pubmed: 10454276
Biol Psychiatry Cogn Neurosci Neuroimaging. 2020 Jun;5(6):562-568
pubmed: 32340927
Brain Behav. 2016 Mar 22;6(4):e00457
pubmed: 27066310
J Neurosci. 2008 Apr 2;28(14):3586-94
pubmed: 18385317
Clin Neurophysiol. 2002 Aug;113(8):1199-208
pubmed: 12139998
Neuroimage. 2019 Apr 1;189:631-644
pubmed: 30639334
eNeuro. 2020 Dec 22;7(6):
pubmed: 32978216
Hum Brain Mapp. 2015 Nov;36(11):4334-45
pubmed: 26350618
Cogn Neurodyn. 2017 Feb;11(1):23-33
pubmed: 28174610

Auteurs

Marco McSweeney (M)

Department of Human Development and Quantitative Methodology, University of Maryland, 3304 Benjamin Building, College Park, MD 20742, USA. Electronic address: mmcsw1@umd.edu.

Santiago Morales (S)

Department of Psychology, University of Southern California, USA.

Emilio A Valadez (EA)

Department of Human Development and Quantitative Methodology, University of Maryland, 3304 Benjamin Building, College Park, MD 20742, USA.

George A Buzzell (GA)

Department of Psychology and the Center for Children and Families, Florida International University, USA.

Lydia Yoder (L)

Department of Human Development and Quantitative Methodology, University of Maryland, 3304 Benjamin Building, College Park, MD 20742, USA.

William P Fifer (WP)

Department of Psychiatry, Columbia University Irving Medical Center, New York, USA; Department of Paediatrics, Columbia University Irving Medical Center, New York, USA; Division of Developmental Neuroscience, New York State Psychiatric Institute, USA.

Nicolò Pini (N)

Department of Psychiatry, Columbia University Irving Medical Center, New York, USA; Division of Developmental Neuroscience, New York State Psychiatric Institute, USA.

Lauren C Shuffrey (LC)

Department of Psychiatry, Columbia University Irving Medical Center, New York, USA; Division of Developmental Neuroscience, New York State Psychiatric Institute, USA.

Amy J Elliott (AJ)

Avera Research Institute, USA; Department of Paediatrics, University of South Dakota School of Medicine, USA.

Joseph R Isler (JR)

Department of Paediatrics, Columbia University Irving Medical Center, New York, USA.

Nathan A Fox (NA)

Department of Human Development and Quantitative Methodology, University of Maryland, 3304 Benjamin Building, College Park, MD 20742, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH